These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21106380)

  • 1. Hypericins and thioredoxin reductase: Biochemical and docking studies disclose the molecular basis for effective inhibition by naphthodianthrones.
    Sorrentino F; Karioti A; Gratteri P; Rigobello MP; Scutari G; Messori L; Bindoli A; Chioccioli M; Gabbiani C; Bergonzi MC; Bilia AR
    Bioorg Med Chem; 2011 Jan; 19(1):631-41. PubMed ID: 21106380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mammalian thioredoxin reductase by black tea and its constituents: implications for anticancer actions.
    Du Y; Wu Y; Cao X; Cui W; Zhang H; Tian W; Ji M; Holmgren A; Zhong L
    Biochimie; 2009 Mar; 91(3):434-44. PubMed ID: 19059456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human selenium-dependent thioredoxin reductase from HeLa cells: properties of forms with differing heparin affinities.
    Gorlatov SN; Stadtman TC
    Arch Biochem Biophys; 1999 Sep; 369(1):133-42. PubMed ID: 10462449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
    Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
    Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
    Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
    Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial thioredoxin reductase purification, inhibitor studies, and role in cell signaling.
    Rigobello MP; Bindoli A
    Methods Enzymol; 2010; 474():109-22. PubMed ID: 20609907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of green tea extract and (-)-epigallocatechin-3-gallate on mammalian thioredoxin reductase and HeLa cell viability.
    Wang Y; Zhang H; Holmgren A; Tian W; Zhong L
    Oncol Rep; 2008 Dec; 20(6):1479-87. PubMed ID: 19020731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis.
    Waksman G; Krishna TS; Williams CH; Kuriyan J
    J Mol Biol; 1994 Feb; 236(3):800-16. PubMed ID: 8114095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
    Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
    Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of thioredoxin reductase by lanthanum chloride.
    Citta A; Folda A; Scutari G; Cesaro L; Bindoli A; Rigobello MP
    J Inorg Biochem; 2012 Dec; 117():18-24. PubMed ID: 23078771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
    Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
    Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the potential of thioredoxin reductase inhibitors for cancer therapy.
    Urig S; Becker K
    Semin Cancer Biol; 2006 Dec; 16(6):452-65. PubMed ID: 17056271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro inhibition of mice thioredoxin reductase by methylmercury.
    Wagner C; Sudati JH; Nogueira CW; Rocha JB
    Biometals; 2010 Dec; 23(6):1171-7. PubMed ID: 20717703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds.
    Casini A; Gabbiani C; Sorrentino F; Rigobello MP; Bindoli A; Geldbach TJ; Marrone A; Re N; Hartinger CG; Dyson PJ; Messori L
    J Med Chem; 2008 Nov; 51(21):6773-81. PubMed ID: 18834187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of calcium ions on the cytosolic and mitochondrial thioredoxin reductase.
    Rigobello MP; Vianello F; Folda A; Roman C; Scutari G; Bindoli A
    Biochem Biophys Res Commun; 2006 May; 343(3):873-8. PubMed ID: 16564501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
    Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
    Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of Arabidopsis thaliana NADPH dependent thioredoxin reductase at 2.5 A resolution.
    Dai S; Saarinen M; Ramaswamy S; Meyer Y; Jacquot JP; Eklund H
    J Mol Biol; 1996 Dec; 264(5):1044-57. PubMed ID: 9000629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic insights into the inhibitory effects of palmitoylation on cytosolic thioredoxin reductase and thioredoxin.
    Qin H; Liang W; Xu Z; Ye F; Li X; Zhong L
    Biochimie; 2015 Mar; 110():25-35. PubMed ID: 25576832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncated mutants of human thioredoxin reductase 1 do not exhibit glutathione reductase activity.
    Urig S; Lieske J; Fritz-Wolf K; Irmler A; Becker K
    FEBS Lett; 2006 Jun; 580(15):3595-600. PubMed ID: 16750198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin.
    Prast-Nielsen S; Cebula M; Pader I; Arnér ES
    Free Radic Biol Med; 2010 Dec; 49(11):1765-78. PubMed ID: 20851179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.